← Leaderboards
Samuel Ng
Division Of Basic Sciences - Nci
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at Division Of Basic Sciences - Nci
Same institution · by research overlap
Others in their field
Top investigators on “Pre-Clinical Model”
- Dennis R. Burton · Scripps Research Institute$257,157,696
- Leonard Freedman · Leidos Biomedical Research, Inc.$255,997,443
- David Heimbrook · Leidos Biomedical Research, Inc.$96,812,185
- Lynn Briscoe · Leidos Biomedical Research, Inc.$95,451,222
- David M Anderson · University Of Washington$94,243,251
- Ronald B Corley · Boston University Medical Campus$80,765,880
Research focus
Pre-Clinical ModelPathway InteractionsT-Cell LymphomaCollaborationsLymphoma CellMolecularMutationSamplingT-LymphocyteCell LineGeneticBiopsy SpecimenEnsureGenerationsEpigenetic ProcessGene ExpressionGenetically Engineered MouseExperimental StudyAddictionGenetic ScreeningCellsClinical TrialsAnimal ModelClinical Application
Grant awards (5)
Targeting exploitable vulnerabilities in T-cell Lymphoma$1,434,488
ZIA · FY2025 · CA · contact PI
Targeting CCR4 in T-cell Lymphoma with CAR T-cell therapy$159,388
ZIA · FY2025 · CA · contact PI
Targeting exploitable vulnerabilities in T-cell Lymphoma$2,233,312
ZIA · FY2024 · CA · contact PI
Targeting exploitable vulnerabilities in T-cell Lymphoma$1,192,732
ZIA · FY2023 · CA · contact PI
Targeting exploitable vulnerabilities in T-cell Lymphoma$361,108
ZIA · FY2022 · CA · contact PI